4//SEC Filing
Hamm John M. 4
Accession 0001628280-25-013513
CIK 0001087294other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 5:06 PM ET
Size
6.7 KB
Accession
0001628280-25-013513
Insider Transaction Report
Form 4
Hamm John M.
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2025-03-16$5.46/sh−5,930$32,378→ 20,073 total - Award
Options (right to buy)
2025-03-17$5.17/sh+2,750$14,218→ 15,250 totalExercise: $5.17From: 2029-03-17Exp: 2035-03-17→ Common Stock (2,750 underlying)
Footnotes (1)
- [F1]This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.
Documents
Issuer
CUMBERLAND PHARMACEUTICALS INC
CIK 0001087294
Entity typeother
Related Parties
1- filerCIK 0001870439
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 5:06 PM ET
- Size
- 6.7 KB